BRCA2Interact · Structural and biochemical characterization of pre-recombination complexes
„Хоризонт 2020“ — Действия „Мария Склодовска-Кюри“
- Период
- 2015-06-01 → 2017-05-31
- Финансиране от ЕС
- 183 455 €
- Участници
- 2
- Схема
- MSCA-IF
Линиите свързват координатора с партньорите.
Накратко на български
Протеините BRCA2, PALB2 и RAD51 се изследват, за да се разбере как те работят заедно при поправянето на повредената ДНК. Това помага за разясняване на молекулярните механизми, които водят до генетична нестабилност и предразполагане към рак.
Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.
Резултати накратко
Structural and biochemical characterization of pre-recombination complexes
(The fellowship described in this report was terminated pre-maturely after 18 months due to additional external funding being awarded to researcher Dr. Peuscher. Future directions of the work described are continueing under this newly awarded fellowship) Our genetic material, the DNA, is continuously subjected to damage. As maintaining genome stability is crucial for cell survival, broken DNA needs to be efficiently repaired. One essential mechanism to repair damaged DNA is homologous recombination (HR), and defects in different HR factors are linked with human disease and cancer pre-disposition. The RAD51 recombinase protein plays a central role in HR, forming filaments at sites of DNA damage and promoting homologous pairing and DNA strand exchange. RAD51 filament formation is mediated by the BRCA2 tumour suppressor protein, mutations in which lead to a high incidence of developing breast cancer. BRCA2 interacts with other HR factors, such as PALB2 and members of the RAD51 paralog family. Many of these proteins also function as tumour suppressors. To understand HR in more detail and gain new insights into the molecular mechanisms underlying genome instability, we have addressed the question how PALB2 and the RAD51 paralogs coordinate their activities with BRCA2 to promote the assembly of RAD51 filaments. Specifically, we have implemented a new protocol for the purification of RAD51, which has allowed us to purify RAD51 protein with improved solubility and activity. This protein is now being used in biochemical analyses and electron microscopy studies. In addition, the BRCA2-PALB2 complex has been purified and preliminary biochemical and structural analyses have been performed using this complex. To extend these studies by inclusion of the RAD51 paralogs, we have tested and optimized cloning and protein purification strategies for the two main paralog complexes. In conclusion, our studies have resulted in the successful purification of different critical HR proteins and complexes which can now be used to characterize the biochemical and structural properties of pre-recombination assemblies in more detail. This will help us to define the functional contribution of each individual protein within those complexes in promoting efficient HR, and teach us more about their role in genome maintenance and tumour avoidance.
Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз
Цел на проекта
Homologous recombination (HR) is an essential DNA repair mechanism and defects in different HR factors are linked with disease and cancer pre-disposition. The RAD51 recombinase plays a central role in HR, forming nucleoprotein filaments at sites of DNA damage and promoting homologous pairing and DNA strand exchange. RAD51 filament formation is mediated by the BRCA2 tumour suppressor, mutations in which lead to a high incidence of developing breast cancer. BRCA2 interacts with other HR factors, such as PALB2 and members of the RAD51 paralog family. Many of these proteins also function as tumour suppressors. The host laboratory has purified full-length BRCA2 protein and shown that it facilitates RAD51-mediated HR by acting as a molecular chaperone for RAD51 filament formation. This offers a unique position to extend our understanding of pre-recombinational protein assembly by inclusion of additional critical HR factors, and answer the important question how PALB2 and the RAD51 paralogs coordinate their activities with BRCA2 to promote the assembly of RAD51 filaments. To achieve this, I propose to:i) Characterize the biochemical and structural properties of RAD51 paralog complexes ii) Define the interplay between BRCA2, PALB2, and the RAD51 paralogs in forming pre-recombination complexes for RAD51 assembly, using biochemical approaches and electron microscopic visualisation.Given the importance of HR and its role in tumour avoidance, I anticipate our results to provide significant new insights into the molecular mechanisms underlying genome instability. Also, they may uncover novel targets for therapeutic intervention for breast cancer. Together, the proposed research will not only substantially advance knowledge of DNA repair but will also provide me with invaluable training in biochemistry, electron microscopy and project management in a world-class research environment. As such, it forms the perfect platform from which to launch my independent research career.
Оригинален текст от CORDIS (на английски).
Участници
- THE FRANCIS CRICK INSTITUTE LIMITED · LondonКоординаторОбединеното кралство
- CANCER RESEARCH UK LBG · LONDONОбединеното кралство
Връзки
Данни: CORDIS, © Европейски съюз
